New findings suggest that targeting inflammation in Alzheimer’s may matter as much as targeting protein buildup.

Researchers are engineering a new class of miniature antibodies, called intrabodies, that can operate inside living cells to ...

New treatments for neurodegenerative diseases like Alzheimer's, Parkinson's, and motor neuron disease (MND) could be unlocked thanks to microscopic medicines developed by researchers at the University ...

Internal medicine doctor diagnosed with Alzheimer's at 57 shares how monoclonal antibody treatment restored his cognitive ...

The causes of Alzheimer’s disease have long puzzled researchers, especially when most older adults show signs of the illness even without carrying the well-known mutations linked to it. In fact, ...

After identifying that accumulation of toxic tau and amyloid proteins in the brain are a feature of Alzheimer’s disease, researchers have, understandably, been working on treatments that reduce or ...

Expecting pivotal data this year, the company has raised a Series C round to support the launch of a noninvasive device ...

Alzheimer's disease affects millions of people worldwide, yet the illness is hardest to catch at the very beginning, when new ...

A new study found that women who test positive for A Parkinson-s related protein accumulated tau at a much faster rate, ...

A team linked to Duke University and the UNC Alzheimer’s Disease Research Center has found that a simple brush swab of the nasal lining can pick up molecular and immune cell changes tied to ...

HHS Secretary Robert F. Kennedy Jr. appointed Michelle Branham as chair of the federal Advisory Council on Alzheimer’s ...

Many Black and Latino families are navigating Alzheimer’s without access to the information, resources, and community support ...